Advertisement

The Scientist

» drug development, immunology and culture

Most Recent

image: Viral Soldiers

Viral Soldiers

By | January 1, 2016

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

11 Comments

image: Speaking of Science 2015

Speaking of Science 2015

By | December 31, 2015

A year’s worth of noteworthy quotes

0 Comments

image: Pregnancy May Explain Ebola Return

Pregnancy May Explain Ebola Return

By | December 21, 2015

Health officials suspect recently reported cases of the disease in Liberia might stem from a flare-up of the virus in a survivor who became pregnant.

0 Comments

image: When the Flu Vax Fails

When the Flu Vax Fails

By | December 16, 2015

The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 

0 Comments

image: First Dengue Vax Approved

First Dengue Vax Approved

By | December 11, 2015

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

0 Comments

image: Another Obesity Drug Trial Death

Another Obesity Drug Trial Death

By | December 2, 2015

A second patient taking an experimental medication to treat Prader-Willi Syndrome has died of blood clots.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | December 1, 2015

Welcome to the Microbiome, The Paradox of Evolution, Newton's Apple, and Dawn of the Neuron.

0 Comments

image: Self Correction

Self Correction

By | December 1, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: Ebola’s Effects on the Eye

Ebola’s Effects on the Eye

By | November 30, 2015

A second doctor shows symptoms of ocular disease after recovering from Ebola infection.

0 Comments

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

Advertisement
Lonza Group
Lonza Group

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Exploring Emotional Contagion
  4. Immune Defect Detected in Knockout Mice
Advertisement
SomaLogic
SomaLogic
Advertisement
Biosearch Technologies
illumina Corporate
illumina Corporate